To register a generic drug in Taiwan, applicants submit an abbreviated application to the TFDA, proving bioequivalence with the original product. The process also requires compliance with Good Manufacturing Practice (GMP), along with manufacturing, quality, and labeling data. If complete, approvals typically occur within 6 to 9 months.